J S Brazier

2.3k total citations
30 papers, 1.3k citations indexed

About

J S Brazier is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, J S Brazier has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 11 papers in Epidemiology and 7 papers in Clinical Biochemistry. Recurrent topics in J S Brazier's work include Clostridium difficile and Clostridium perfringens research (26 papers), Microscopic Colitis (11 papers) and Viral gastroenteritis research and epidemiology (9 papers). J S Brazier is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (26 papers), Microscopic Colitis (11 papers) and Viral gastroenteritis research and epidemiology (9 papers). J S Brazier collaborates with scholars based in United Kingdom, Italy and Belgium. J S Brazier's co-authors include Michel Delmée, Frédéric Barbut, Ian R. Poxton, Ed J. Kuijper, Paola Mastrantonio, B. I. Duerden, M M Brett, J. C. Hood, Maja Rupnik and Phillippa Cumberland and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

J S Brazier

30 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J S Brazier United Kingdom 18 1.2k 667 169 162 130 30 1.3k
Carol J. Shanholtzer United States 17 815 0.7× 694 1.0× 164 1.0× 199 1.2× 126 1.0× 32 1.4k
R Y Kwok United States 11 1.4k 1.2× 866 1.3× 183 1.1× 298 1.8× 110 0.8× 16 1.5k
Béatrice Burghoffer France 19 1.2k 1.0× 820 1.2× 173 1.0× 166 1.0× 214 1.6× 28 1.6k
Fabrizio Barbanti Italy 24 1.1k 1.0× 564 0.8× 225 1.3× 142 0.9× 251 1.9× 51 1.4k
H Elliott Larson United Kingdom 20 1.4k 1.2× 748 1.1× 186 1.1× 149 0.9× 251 1.9× 31 1.8k
Nadine M. Sullivan United States 17 880 0.8× 554 0.8× 195 1.2× 82 0.5× 228 1.8× 25 1.5k
Dale N. Gerding United States 15 1.4k 1.2× 936 1.4× 303 1.8× 294 1.8× 155 1.2× 17 1.7k
Sandra Willey United States 13 686 0.6× 440 0.7× 76 0.4× 164 1.0× 174 1.3× 13 1.3k
Lily O’Connor United Kingdom 14 1.6k 1.3× 1.1k 1.6× 276 1.6× 319 2.0× 362 2.8× 20 2.0k
M. Marín Spain 18 698 0.6× 604 0.9× 238 1.4× 138 0.9× 132 1.0× 28 1.1k

Countries citing papers authored by J S Brazier

Since Specialization
Citations

This map shows the geographic impact of J S Brazier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J S Brazier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J S Brazier more than expected).

Fields of papers citing papers by J S Brazier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J S Brazier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J S Brazier. The network helps show where J S Brazier may publish in the future.

Co-authorship network of co-authors of J S Brazier

This figure shows the co-authorship network connecting the top 25 collaborators of J S Brazier. A scholar is included among the top collaborators of J S Brazier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J S Brazier. J S Brazier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brazier, J S, Jonathan Sinclair, & Lindsay Bottoms. (2014). THE EFFECTS OF HOLOGRAM WRISTBANDS AND PLACEBO ON ATHLETIC PERFORMANCE. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 46(1). 109–116. 2 indexed citations
2.
Miyajima, Fábio, Paul Roberts, Andrew Swale, et al.. (2011). Characterisation and Carriage Ratio of Clostridium difficile Strains Isolated from a Community-Dwelling Elderly Population in the United Kingdom. PLoS ONE. 6(8). e22804–e22804. 53 indexed citations
3.
Jamal, Wafaa, Vincent O. Rotimi, J S Brazier, & B. I. Duerden. (2010). Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period. Anaerobe. 16(6). 560–565. 37 indexed citations
4.
Morgan, Oliver, et al.. (2008). Clinical Severity of Clostridium difficile PCR Ribotype 027: A Case-Case Study. PLoS ONE. 3(3). e1812–e1812. 88 indexed citations
5.
6.
Brazier, J S, Bhavika B. Patel, & A. Pearson. (2007). Distribution of Clostridium difficile PCR ribotype 027 in British hospitals. Weekly releases (1997–2007). 12(17). E070426.2–E070426.2. 31 indexed citations
7.
Wultańska, Dorota, Aleksandra Banaszkiewicz, Andrzej Radzikowski, et al.. (2007). P1544 Survey of Clostridium difficile infection and faecal lactoferrin in Polish paediatric patients with infiammatory bowel disease. International Journal of Antimicrobial Agents. 29. S433–S433. 1 indexed citations
8.
Gal, Micaela, et al.. (2005). Subtyping of Clostridium difficile polymerase chain reaction (PCR) ribotype 001 by repetitive extragenic palindromic PCR genomic fingerprinting. Journal of Hospital Infection. 60(1). 56–60. 16 indexed citations
9.
Brett, M M, J. C. Hood, J S Brazier, B. I. Duerden, & Susan Hahné. (2005). Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom. Epidemiology and Infection. 133(4). 575–582. 71 indexed citations
10.
Wareham, David W., et al.. (2005). Anaerobic Sepsis Due to Multidrug‐ResistantBacteroides fragilis:Microbiological Cure and Clinical Response with Linezolid Therapy. Clinical Infectious Diseases. 40(7). e67–e68. 55 indexed citations
11.
12.
Brazier, J S, Micaela Gal, Val Hall, & Trefor Morris. (2004). Epidémie d’infections à Clostridium histolyticum chez les utilisateurs de drogues injectables en Angleterre et en Ecosse. Eurosurveillance. 9(9). 1–2. 4 indexed citations
13.
Brazier, J S, Micaela Gal, Victoria Hall, & Trefor Morris. (2004). Outbreak of Clostridium histolyticum infections in injecting drug users in England and Scotland. Eurosurveillance. 9(9). 1–2. 12 indexed citations
14.
Brazier, J S, Trefor Morris, & B. I. Duerden. (2003). Heat and acid tolerance of Clostridium novyi Type A spores and their survival prior to preparation of heroin for injection. Anaerobe. 9(3). 141–144. 6 indexed citations
15.
Barbut, Frédéric, Michel Delmée, J S Brazier, et al.. (2003). A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clinical Microbiology and Infection. 9(10). 989–996. 97 indexed citations
16.
Brazier, J S. (2001). The European Society of Clinical Microbiology and Infectious Diseases Study Group on Clostridium difficile (ESGCD). Clinical Microbiology and Infection. 7(8). 404–404. 1 indexed citations
17.
Brazier, J S. (1998). The diagnosis of Clostridium difficile-associated disease. Journal of Antimicrobial Chemotherapy. 41(suppl 3). 29–40. 73 indexed citations
18.
Brazier, J S, et al.. (1997). Preliminary Findings of the International Typing Study onClostridium difficile. Clinical Infectious Diseases. 25(s2). S199–S201. 22 indexed citations
19.
Brazier, J S. (1995). An International Study on the Unification of Nomenclature for Typing Clostridium difficile. Clinical Infectious Diseases. 20(Supplement_2). S325–S326. 2 indexed citations
20.
Brazier, J S & Val Hall. (1994). A simple evaluation of the AnaeroGenTMsystem for the growth of clinically significant anaerobic bacteria. Letters in Applied Microbiology. 18(1). 56–58. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol J. Shanholtzer Breakdown of academic impact, for papers by R Y Kwok Breakdown of academic impact, for papers by Béatrice Burghoffer Breakdown of academic impact, for papers by Fabrizio Barbanti Breakdown of academic impact, for papers by H Elliott Larson Breakdown of academic impact, for papers by Nadine M. Sullivan Breakdown of academic impact, for papers by Dale N. Gerding Breakdown of academic impact, for papers by Sandra Willey Breakdown of academic impact, for papers by Lily O’Connor Breakdown of academic impact, for papers by M. Marín
Rankless by CCL
2026